Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Mari Hosonaga1,2, Hideyuki Saya1, Yoshimi Arima3

  • 1Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Insights

Brain metastasis is common in HER2-positive and triple-negative breast cancer, with poor outcomes. Understanding cancer cell and brain microenvironment interactions may reveal new therapeutic targets to improve survival.

Area of Science:

  • Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Brain metastasis is a frequent and serious complication of certain breast cancer subtypes, particularly HER2-positive and triple-negative breast cancer.
  • Despite advances in primary tumor treatment, the prognosis for patients with brain metastases remains poor, highlighting an unmet clinical need.
  • The molecular and cellular mechanisms driving brain metastasis are complex and not fully understood.

Purpose of the Study:

  • To review the intricate interactions between metastatic cancer cells and the brain microenvironment.
  • To elucidate the role of these interactions in facilitating brain metastasis.
  • To identify potential therapeutic targets within these cellular and molecular pathways.

Main Methods:

  • Review of recent scientific literature on breast cancer brain metastasis.
  • Analysis of molecular and cellular signaling pathways involved in cancer cell-microenvironment interactions.
  • Focus on the roles of astrocytes and microglia in the metastatic process.

Main Results:

  • Complex interactions between cancer cells and brain microenvironment cells (astrocytes, microglia) are crucial for metastasis.
  • Activation of specific signaling pathways in both cancer cells and the brain microenvironment promotes tumor spread.
  • These interactions represent potential targets for novel therapeutic strategies.

Conclusions:

  • Understanding the crosstalk between breast cancer cells and the brain microenvironment is key to improving treatment outcomes.
  • Targeting these specific cellular and molecular interactions offers a promising avenue for developing new therapies against brain metastases.
  • Further research into these pathways could significantly enhance survival rates for affected patients.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K